Home Photos Surgery Types Cosmetic Surgeons Surgery Prices Surgery Risks Plastic Surgery News

Key US drug panel rejects Sanofi's obesity pill (AFP)

Picture shows Parmaceutical group Sanofi-Aventis' logo. A US Food and Drug Administration panel of experts concluded Wednesday that pharmaceutical giant Sanofi-Aventis's obesity treatment Acomplia was unsafe and should not be sold in the United States.(AFP/File/Damien Meyer)AFP - A US Food and Drug Administration panel of experts concluded Wednesday that pharmaceutical giant Sanofi-Aventis's obesity treatment Acomplia was unsafe and should not be sold in the United States.


More: continued here





You can respond, or trackback from your own site.


Related News

  • Panel rejects new weight-loss drug (AP)
  • FDA Approves CustomVue Monovision LASIK (U. S. Food and Drug Administration)
  • Sanofi withdraws anti-obesity drug in US (AFP)
  • Sanofi-Aventis withdraws anti-obesity drug from sale in Europe (AFP)
  • Sanofi pulls obesity drug application in U.S. (Reuters)
  • FDA Responds to Lasik Feedback
  • Sanofi obesity drug faces tough EU safety review (Reuters)
  • Alcon Gets FDA Nod For Triesence Drug Forbes
  • Hollis-Eden Pharmaceuticals Announces Filing of IND for Phase I/II Clinical Trials with HE3286 in Diseases of ... (Business Wire via Yahoo! Finance)
  • Allergan drug gets label extension (bizjournals.com via Yahoo! Finance)


    • Leave a Reply
    Cosmetic Surgery Procedure.com | Cosmetic Surgery Types | Find a Cosmetic Surgeon | Cosmetic Surgery Prices | Cosmetic Surgery Risks | Resources | Contact Us